Ardelyx Inc (ARDX)
6.82
+0.16
(+2.40%)
USD |
NASDAQ |
Oct 04, 16:00
6.81
-0.01
(-0.15%)
After-Hours: 20:00
Ardelyx Shareholders Equity (Annual): 166.82M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 166.82M |
| December 31, 2022 | 98.33M |
| December 31, 2021 | 82.62M |
| December 31, 2020 | 126.11M |
| December 31, 2019 | 186.66M |
| December 31, 2018 | 115.81M |
| Date | Value |
|---|---|
| December 31, 2017 | 139.31M |
| December 31, 2016 | 193.15M |
| December 31, 2015 | 108.90M |
| December 31, 2014 | 60.68M |
| December 31, 2013 | -7.324M |
| December 31, 2012 | -1.237M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
82.62M
Minimum
2021
186.66M
Maximum
2019
132.11M
Average
126.11M
Median
2020
Shareholders Equity (Annual) Benchmarks
| Enanta Pharmaceuticals Inc | 216.74M |
| Sage Therapeutics Inc | 799.53M |
| Verve Therapeutics Inc | 599.50M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -0.1115M |